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BPV-1 genomeThe multifunctional papillomavirus E2 protein serves important roles in transcriptional activation and
genome maintenance and cooperates with the viral E1 helicase for the initiation of viral DNA replication. The
bovine papillomavirus genome contains seventeen E2 binding sites, largely concentrated within the long
control region, and a single E1 binding site at the origin of viral replication. Using chromatin
immunoprecipitation (ChIP) followed by restriction enzyme digestion and PCR, we show that BPV E1 was
present only in the region of an active origin of replication and that BPV E2 remained attached to deﬁnable
segments of the viral genome at speciﬁc stages of the cell cycle.
© 2009 Elsevier Inc. All rights reserved.Introduction
Papillomaviruses (PV) are responsible for a variety of benign and
malignant epithelial lesions including carcinoma of the cervix (Zur
Hausen, 2002). Papillomavirus genomes consist of approximately
8 kilobases of double stranded DNA that, upon infection, are stably
maintained as low copy episomes in the basal layer of epithelial cells
until induced by cellular differentiation to initiate programmed viral
genome ampliﬁcation. Bovine papillomavirus type 1 (BPV-1) has been
historically utilized as a model for the study of PV genome replication.
BPV-1 genomic or sub-genomic DNAs that are transfected into murine
C127 and NIH3T3 cell lines can replicate autonomously, displaying a
stable copy number and expressing the essential early viral proteins
(Law et al., 1981). The murine C127 cell line is also transformed by
BPV-1 without integration of viral DNA into the host genome. The
mechanism of cell transformation by BPV-1 is still not fully
understood, however both the BPV-1 E5 and E6 proteins efﬁciently
perform this task (Bergman et al., 1988; Schiller et al., 1984).
Themajor function of E2 is regulation of BPV-1 transcription. The N-
terminal two-thirds of E2 encodes a potent transcriptional activation
domain (TAD) that stimulates expression from E2 binding site contain-
ing reporters in mammalian and yeast cells (Haugen et al., 1987;
Morrissey et al., 1989; Spalholz et al., 1985; Stanway et al., 1989). E2,
through its C-terminal domain, binds to a speciﬁc palindromic sequence
found in all PVs (Androphy et al., 1987; McBride et al., 1988; Sedman. Androphy).
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afﬁnities within the BPV-1 genome (Li et al., 1989), the majority of
which are clustered in the long control region (LCR), which includes the
major promoter elements and the viral origin (Fig. 1). Several E2binding
sites appear adjacent to promoters within the E1 and E2 genes.
In addition to its function in transcriptional activation, the E2protein is
necessary for both transient replication and persistence of replicated viral
episomes. BPV and HPV genomes have been shown to associate with
cellular chromatin duringmitosis. This is thought to retain viral episomes
following dissolution of the nuclear envelope in order to ensure equal
partitioning of newly replicated PV into emerging daughter cells (Ilves et
al., 1999; Lehman and Botchan, 1998). The E2 C-terminal DNA binding
domain identiﬁes the viral genome, while cellular factors that interact
with the N-terminal transactivation domain (TAD) facilitate genomic
tethering tomitotic chromosomes (Abroi et al., 2004). The cis-acting sites
involved in mitotic segregation of the viral genome were deﬁned by
deletional studies and overlap the cluster of E2 binding sites in the 5′ BPV-
1 LCR. This region has been labeled as theminichromosomemaintenance
element (MME) (Abroi et al., 2004; Lehman and Botchan, 1998; Pirsoo et
al., 1996). The trans factors that connect E2 tomitotic chromosomes have
been intensively studied. Our lab reported that the interaction of E2 with
ChlR1, a DNA helicase involved in establishment of proper chromatid
cohesion, is necessary for maintenance of viral episomes (Parish et al.,
2006).While itwas proposed that the bromodomain protein Brd4 tethers
E2 proteins to mitotic chromosomes more recent investigations indicate
that Brd4 is also necessary for the transcriptional functions of E2 (Ilves et
al., 2006; McPhillips et al., 2006; Schweiger et al., 2007; Wu et al., 2006;
You et al., 2004).
E1 and E2 are the only viral proteins required for transient
replication of the genome (Mohr et al., 1990; Sedman and Stenlund,
1995; Ustav and Stenlund, 1991). The E1 protein is an ATP dependent
Fig. 1. Schematic of the BPV-1 genome showing E1 and E2 binding sites. E2 binding sites are shown as numbered boxes 1–17. Symbols on the upper line represent BanII restriction
sites outside the viral LCR. The viral origin is depicted between E2 sites 11 and 12. The LCR sense and antisense primers which ﬂank the BglI and BanII cut sites are represented by
dashed arrows; the primers for the origin are shown as simple arrows, with the primers for the upstream region of the LCR which ﬂank only the BanII cut site represented by ball and
arrow. The letters A, B and C represent primer pairs listed in Materials and methods.
Fig. 2. A3 cells, ID13 cells and the parental cell line C127, were lysed and
immunoprecipitated with monoclonal antibody to BPV-1 E2 (B201). The proteins
were immunoblotted using the rabbit antibody II-1 and visualized with the Thermo-
scientiﬁc dura ECL detection kit (top panel). A3, ID13 and C127 cells were blocked
overnight in 5 mM thymidine and BPV-1 E1 was immunoprecipitated using the 502-2
rabbit antibody. E1 was then detected with 502-2 (center panel). A3 cells were blocked
in thymidine (lane 2), uncycled (lane 3) or blocked overnight with nocodazole (lane 4)
and immunoprecipitated and blotted with the 502-2 rabbit antibody. Lane 1 shows
thymidine treated C127 cells (bottom panel).
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Stenlund, 1995; Ustav et al., 1993). In a cell free system, E1 can initiate
DNA replication in the absence of the viral E2 protein (Grossel et al.,
1996; Lusky et al., 1993). The role of the E2 binding sites in replication
in vivo has been characterized by transfection of engineered plasmids
with mutant LCR constructs along with E1 and E2 expression
plasmids, and in cell lines stably expressing E1 and E2 (Liang and
Botchan, 1990; Lusky et al., 1993, 1994;Mohr et al., 1990; Sedman and
Stenlund, 1995; Ustav et al., 1993; Ustav and Stenlund, 1991). In vitro
and in vivo data demonstrated that a functional origin for transient
replication consisted of E2 binding site 12 (BS12) ﬂanking an E1
speciﬁc binding sequence (Lusky et al., 1993; Sedman and Stenlund,
1995; Ustav et al., 1993). The prevailingmodel is that E2 directly binds
and targets E1 to the origin (Mohr et al., 1990). In vitro and structural
data indicate that E2 must dissociate from E1 to allow for assembly of
E1 double hexamers and initiation of DNA replication (Abbate et al.,
2004; Lusky et al., 1994; Sedman and Stenlund, 1996, 1998; Yang
et al., 1993). The experiments presented herein provide physical
evidence to support this model as we detected the presence of both E1
and E2 at the origin in vivo during G1/S.
In this report we used a modiﬁed chromatin immunoprecipitation
(ChIP) assay to deﬁne the segments of the BPV-1 episome that
interact with E2 and E1 during cell cycle in monolayer cultures of
transformed mouse cells. Published data would suggest that E2 is
released from the E1 complex that assembles on the origin during
G1/S phase; however the question remains what happens to E2
between G1/S and mitosis? Our ChIP protocol was modiﬁed to
include restriction enzyme digestion, following immunoprecipitation
to release segments of the viral genome that were not cross-linked to
the E2 complexes. Bound regions of the DNAwere differentiated using
speciﬁc primers and ampliﬁcation by polymerase chain reaction
(PCR). Since sonication stochastically disrupts DNA, this modiﬁed
protocol allows for ﬁner resolution of binding site occupancy. With
this assay we show binding of E2 to speciﬁc sites in different phases of
the cell cycle and place E1 at the origin at initiation of viral replication.
Results
To investigate E2 binding site occupancy in vivo, we used the C127
cell lines ID13 and A3 that stably replicate andmaintain BPV-1. The A3
genome contains three serine-to-alanine mutations in the hingeregion of the E2 protein at amino acids 290, 298 and 301. These
mutations stabilize the E2 protein and result in increased average
genome copy number (Lehman and Botchan, 1998; Lehman et al.,
1997; McBride and Howley, 1991). To initiate the ChIP studies, it was
ﬁrst necessary to test the efﬁcacy of the available antibodies to the
BPV-1 proteins. A rabbit antibody to E2 (II-1) was used in
immunoprecipitations from ID13 and A3 cells along with the parental
C127 cell line. Detection on an immunoblot was achieved with the
monoclonal E2 antibody B201 (Fig. 2 top panel). It is interesting to
note that the C-terminal repressor form of E2 (E2R) (Hubbert et al.,
1988; Lambert et al., 1987) was not detected in the A3 cell lysates. The
BPV-1 E1 protein is expressed at low levels in cells that stably
replicate viral episomes. Prior to this study detection of E1 has been
largely restricted to overexpression systems and natural expression
has been rarely visualized (Sun et al., 1990). Here the BPV-1 E1
Fig. 4. A3 cells were synchronized using either 5 mM thymidine to block in G1/S
(forefront), 100 ng/ml nocodazole to block in mitosis (center plot), or were left
untreated (rear plot), for 12 to 16 h then harvested and stained with propidium iodide
for FACS (A). Cycled cells were harvested and ChIP assays performed using E1 antibody
502-2, the E2 antibody II-1 or rabbit pre-immune serum (B).
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to its C-terminal 20 amino acids (Fig. 2, middle panel). An additional
immunoblot was performed in an attempt to detect E1 in synchro-
nized A3 cells. E1 was present at detectable levels in asynchronous
cells and cells blocked at G1/S, but not in mitotic A3 cells (Fig. 3,
bottom panel).
Utilizing these antibodies, we attempted to determine E2 site
occupancy in asynchronous A3 cells in a segment of the PV DNA LCR
(nucleotides 7522-67, primer set C Fig. 1) that spans the viral origin
and the surrounding E2 binding sites. Pre-immune rabbit serum and
the EE monoclonal antibody were included as negative controls.
Following ChIP with both the rabbit E2 antisera containing the II-1
antibody and the B202 monoclonal E2 antibody DNA products were
detectable with 25 cycles of standard PCR (Fig. 3A). Using asynchro-
nous A3 cells, ChIP was performed using anti-BPV-1 E1 antibodies
developed in this lab. Three rabbit antibodies were used to detect E1
on the viral genome, utilizing rabbit pre-immune serum and EE
antibody as negative controls and the E2 II-1 antibody as a positive
control. The 1NA antibody (raised to the N-terminal 24 kDa of BPV-1
E1 expressed in Escherichia coli), and two C-terminal antibodies, 1C1
and 502-2 (raised to the C-terminal 36 kDa and a C-terminal 20 amino
acid peptide of E1, respectively), co-precipitated the BPV-1 origin in
synchronized cells following 27 cycles of standard PCR (Fig. 3B). This
places both E1 and E2 in the region of the origin of replication and
demonstrates the speciﬁcity of the ChIP by utilizing antibodies to
several different epitopes of both proteins to detect them in
association with the viral genome.
To determine whether E2 and E1 were associated with the BPV-1
episome during G1/S and in mitosis, A3 cells were effectively
synchronized in G1/S using 5 mM thymidine (16 h ) and blocked in
mitosis using 100 ng/ml nocodazole (12 h ), with well deﬁned peaks
visualized using ﬂow cytometry analysis (Fig. 4A). Sub-conﬂuent
asynchronous cells were distributed throughout the cell cycle with
the majority in G1. ChIPs performed on these synchronized cells
illustrated the ability to detect E2 associated with viral DNA (Fig. 4B).
However, E1 only associated with viral genomes in asynchronous and
G1/S cells and not in nocodazole arrested cells. E1 was not detectable
in an immunoblot of nocodazole blocked A3 (Fig. 2) consistent with
data that E1 is degraded following S phase (Malcles et al., 2002).
E2 binding site occupancy was assessed in cycled A3 cells. The
majority of E2 binding sites in the BPV-1 genome are located in the
LCR, with some as few as 17 bases apart, as illustrated in Fig. 1. A
restriction enzyme digest was added to the ChIP protocol (RestrictionFig. 3. A3 cells were harvested for ChIP assay. PCR was performed for the BPV LCR on
samples immunoprecipitated with the anti-BPV E2 rabbit antibody II-1, a pre-immune
rabbit sera (PB), the mouse monoclonal antibody to BPV E2 (B202) or the mouse
monoclonal antibody to the epitope tag EE (c 452) 0.1% input was included for
reference, along with negative and positive controls for the PCR (A). ChIP samples using
anti-BPV1 rabbit E2 antibody II-1, anti-BPV-1 E1 rabbit antibodies 1NA, 1C1, 502-2, pre-
immune serum and EE antibody as negative controls. PCR negative control and a BPV-1
genome positive control lanes were included. Lane 1 in both ﬁgures is a 100 bp
molecular weight marker (B).Enzyme ChIP (RED-ChIP)) to discriminate between these LCR
segments. Three sets of primers were designed to distinguish ChIP
products in adjacent regions of the LCR as depicted in Fig. 1. Set (A)
ampliﬁes a product spanning nucleotides 7867–297, includes the viral
origin and is 3′ to both the BanII and BglI sites. Primer set (B)
encompasses nucleotides 7205–7685 and ampliﬁes DNA5′ to the BPV-
1 origin and the BglI restriction enzyme recognition sequence. Primer
set C will amplify nucleotides 7522–67 and spans both the BanII and
BglI restriction sites used in this assay (Figs. 3A, B, and 4B). Inclusion of
restriction digest by BglI prior to PCR facilitated the examination of the
LCR at the origin of replication by releasing adjacent genomic DNA and
allowing for speciﬁc detection of either the origin (primer set A) or the
E2 binding cluster (primer set B) by PCR. Inclusion of digestion with
BanII further demonstrates speciﬁcity of binding to the upstream E2
cluster by preferentially eliminating this PCR product following a ChIP
of this region of the genome.Digestionwith BanII at nucleotide 7653 or
BglI at 7832 will interfere with ampliﬁcation using primer set C, and
the absence of a PCR product indicates the digestion is virtually
complete. The LCR fragment ampliﬁed by primer set C was immuno-
precipitated by E2 and E1 antibodies in undigested samples (Fig. 5C)
and, as predicted, digestion with either BanII or BglI prior to PCR
resulted in absence of this product when RED-ChIP was applied to
thymidine blocked A3 cells and binding to the BPV-1 origin was
subsequently examined by PCR.
We used RED-ChIP to determine whether E2 is associated with
sequences in the MME upstream of the viral origin. Fig. 5B shows
results of immunoprecipitation and PCR with primer set B (7205–
7685) from thymidine blocked A3 cells. This region of the DNA
contains a cluster of E2 binding sites (sites 1–8) that overlap theMME.
E2 antibodies immunoprecipitated this region using both standard
ChIP and RED-ChIP (BglI). PCR in the BanII digested lane was
attenuated due to the location of the BanII restriction site between
the set B primers, indicating that E2 is present at the MME in cells
arrested at G1/S. E1 did not bind this region of the viral genome using
either standard ChIP conditions or in digested ChIP samples.
To establish whether E1 and E2 are present at the origin of
replication, the RED-ChIP assay was used again in A3 cells blocked at
G1/S. Nucleotides 7867–297 encompass BPV-1 binding sites 11 and
12 as well as the BPV-1 origin of replication and are 3′ to both the
Fig. 5. A3 cells were synchronized and harvested for ChIP assay. Lysates were digested with either Bgl I or Ban II then immunoprecipitated with 502-2, II-1 or pre-immune sera. (A)
PCR reactions were performed for the BPV origin of replication; (B) the region of the LCR immediately upstream of the origin, or (C) spanning the origin and upstream regions. The
ﬁgure on the right is a schematic representation of primer usage with A, B and C representing primer pairs and ampliﬁed regions as described in Materials and methods.
Fig. 6. A3 cells were synchronized and E2 was immunoprecipitated without digestion
(lane1) or digested with BglI and PﬂM1 (lane 2). Lane 3 is undigested ChIP sample using
rabbit pre-immune serum, and input DNA diluted 1:10 is also shown (lane 4). PCR was
performed using either primers for the LCR of BPV, for nucleotides 5638–6039 in the L1
region, or for nucleotides 2952–3085 ﬂanking E2 binding sites 16 and 17. The bands
obtained from PCR were then quantiﬁed relative to input DNA levels using ImageJ
software. Negative values are shown as 0.00.
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with primer set A. In cells blocked in G1/S both E1 and E2 bound to the
genome at the origin of replication and immunoprecipitated with the
corresponding 502-2 and II-1 antibodies (Fig. 5A). The results from
ChIP and RED-ChIP utilizing these three sets of PCR primers indicate
that E2 binds to distinct regions in the viral LCR, in the upstream E2
cluster and at the origin of replication at the onset of S phase. E1,
however, could only be detected in the immediate vicinity of the viral
origin.
To acquire a more complete picture of the association of E2 with
other binding sites distributed over the entire genome, additional
RED-ChIP assays were performed on A3 cells blocked at G1/S
(thymidine), and at the onset of mitosis (nocodazole), or in uncycled
cells (asynchronous). Standard ChIP assays with PCR primer set C and
the II-1 E2 antibody detected binding of the protein to the LCR (Fig. 6
lane 1 LCR in panels A, B and C), as would be expected from previous
results (see Fig. 3). Samples were also digested with the restriction
enzymes PﬂM1 (nucleotide 3682) and BglI (RED-ChIP (PﬂM1, BglI)
Fig. 6, lane 2). The result of this digestion is the formation of a segment
of viral DNA encompassing nucleotides 3682–6531 that contains no
predicted E2 binding sequences (see Fig. 1). Subsequently, a RED-ChIP
(PﬂM1, BglI) with the II-1 E2 antibody would be expected to yield no
PCR product in thymidine and/or nocodazole blocked cells using
primers to detect this region of the viral genome (nucleotides 5638–
6039) in the L1 coding sequence (primer set L1). The L1 primer set
was used for PCR on the same samples in which E2 binding to the LCR
was detected. There was no sequence speciﬁc binding of E2 in
digested or undigested samples, consistent with the absence of E2
binding sites in the L1 coding region (Fig. 6, lane 2, L1, A, B and C).
Near complete digestion by BglI is demonstrated by a lack of product
in lane 2 in all LCR samples (Fig. 6 lane 2, LCR, A, B and C). The viral
sequences ﬂanked by the BglI restriction site at 2818 and the PﬂM1
site at 3682 contain E2 binding sites, 16 and 17 (Fig. 1). We attempted
to detect binding of E2 to this region in ChIP assays using primers for
nucleotides 2953–3085; however, E2 binding was not observed in
undigested or digested samples (Fig. 6, lanes 1 and 2, BS 16 and 17).
Therefore, interaction of E2 in vivo with sites outside the LCR in anyphase of the cell cycle was not detected (compare thymidine,
asynchronous and nocodazole groups, Fig. 6). The results of this PCR
assay were quantiﬁed using ImageJ software and are shown beneath
each panel in Fig. 6. Background was subtracted (pre-immune serum
lane 3) and data are relative to input for each sample.
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While extensive work has been undertaken to characterize the E2
binding sites within the genome of the bovine papillomavirus, the
majority of these studies utilized either puriﬁed proteins or in vivo
techniques where E1, E2 and portions of the viral LCR were
transfected into cell lines (Chiang et al., 1992; Ilves et al., 1999;
Liang and Botchan, 1990; Lusky et al., 1994; Mohr et al., 1990; Pirsoo
et al., 1996). These model systems utilized E1 and E2 at levels higher
than endogenously expressed and do not account for the inﬂuence of
the cell cycle on viral protein levels, expression, modiﬁcation or
nuclear localization. In our ChIP assays we utilized the C127 A3 cell
line that maintains the full BPV-1 genome with serine-to-alanine
mutations in the E2 protein at amino acids 290, 298 and 301. Levels of
E2 and E1 are predicted to be higher in this cell type since in wild type
BPV-1, phosphorylation, ubiquitination and degradation of E2 seem to
rely heavily on phosphorylation at serine 301 (McBride and Howley,
1991). While mutation of this serine alone resulted in elevated levels
of E2 and increased viral DNA copy number, the genome appears to
otherwise replicate and be maintained in a manner consistent with
previous ﬁndings (Lehman et al., 1997; Penrose and McBride, 2000).
This phenotype may be enhanced by the absence of BPV-1 E2R
normally expressed by wild type BPV-1, however as there has been no
role shown for E2R in stable genome maintenance, the loss of this
protein would have a negligible effect on the results of ChIP in mitotic
cells (Fig. 2) (Lambert et al., 1990). The antibodies developed in our
lab are not able to differentiate between E2 and E2R and the lack of
E2R simpliﬁes the interpretation of the data-only full length E2 is
found bound to these consensus sequences.
Traditional ChIP has been used to distinguish between closely
aligned transcription factor binding sites within cellular genomic DNA
utilizing only sonication to disrupt the chromatin. Sonication results
in variably sized fragments with no consistent restriction points. Most
often, sonication alonewas unable to disrupt the genome between the
E2 binding sites of the BPV-1 LCR. The combination of traditional ChIP
with restriction enzyme digestion (RED-ChIP) allowed us to detect
speciﬁc binding of BPV-1 E2 with its predicted sites in the BPV-1 LCR,
and helped demonstrate a lack of binding at predicted sites outside
the LCR in a monolayer cell culture system. The BPV-1 E2 binding sites
have been determined by sequence similarity and detection of E2
bound to DNA in vitro using EMSA (Li et al., 1989). The afﬁnity of
several of these binding sites is remarkably low, and they are not
conserved among HPV types, leading us to question their function-
ality. While binding of E2 to it sequences outside the viral LCR does
not appear to be required for growth or maintenance of BPV-1 in
monolayer culture, it is possible that these are utilized for ampliﬁca-
tion of the viral genome in differentiated epithelial cells. It is also
interesting that the inability to detect the E2R protein in A3 cells
correlates with the absence of E2 at the putative E2R promoter. Why
the A3mutant of E2 did not bind to this site in vivo is uncertain. It may
be that binding to these sites is below the level of detection of our
assay conditions.
While the A3 cell line performed relatively well when synchro-
nized, there were minor limitations imposed on this study by the
irregularity of cycling. Serum starvation did not maintain cells in G1.
Thymidine blocks cells at the initiation of replication by inhibiting the
synthesis of deoxycytidine and initiating the DNA repair response.
This stalls the progress of replication forks and delays the transition
into S phase (Bjursell and Reichard, 1973; Xeros, 1962) and here was
employed to analyze cells at the border of G1/S to investigate E1 and
E2 at the onset of replication. A double thymidine block is the more
common approach, however this resulted in a signiﬁcant amount of
cell death. As shown in Fig. 3A, a single thymidine block was
successful at stalling the majority of cells at G1/S and was the
preferable method. Cells released from a single thymidine block did
not progress into S phase as a synchronous population and therefore itwas not possible to examine E2 binding as cells exit S phase and enter
G2/M. We thus resorted to the use of nocodazole to examine E2
binding to the genome of cells blocked in mitosis. Nocodazole acts as a
microtubule depolymerizing agent and prevents assembly of the
mitotic spindle required for genome segregation, effectively accumu-
lating cells in prometaphase. Nocodazole does not interfere with BPV-
1 E2 mediated segregation of the viral episome, which does not
require mitotic spindle formation (Dao et al., 2006), nor should it
interfere with Brd4 mediated attachment to chromatin, as Brd4 has
been shown to localize to condensed chromatin with only minor
staining visible on mitotic spindles (Abbate et al., 2006; You et al.,
2004). Although Brd4 is a potential candidate for the cellular protein
required for viral tethering neither our lab (data not shown) nor Ilves
et al., were able to place Brd4 on the viral genome in mitotic cells
using chromatin immunoprecipitation (Ilves et al., 2006). ChIP has
been shown to be relatively sensitive; however, it is possible that the
binding of Brd4 to the genome was below the level of detection of our
assay or that Brd4 epitopes were unavailable in a chromatin-
associated complex.
Our data reveal that E2 remains associated with the BPV-1 LCR
throughout the cell cycle, and localized to the origin and MME during
S phase. It has been reported that central LCR E2 binding sites,
predominantly sites 5–8, are the cis element required for BPV-1
genome tethering (Pirsoo et al., 1996). Our results conﬁrm that the E2
protein is speciﬁcally bound at the MME region of the viral genome
during mitosis.
BPV-1 E2 binding sites 11 and 12 ﬂank the viral origin. It has been
reported that the binding of E1 to the viral origin excludes E2 from
BS12 (Lusky et al., 1994). Our data do not distinguish speciﬁc binding
of E2 to either BS12 or the nearby BS11 during assembly of the
replication complex (Fig. 5). We could not demonstrate that E1 is
present on the origin while E2 is bound to BS12. The use of sequential
ChIP of the origin would be necessary to show concurrent association
of both viral proteins. Attempts at this technique were not effective
due to high background. Additional restriction enzyme digestion
would also be required to differentiate between binding of E2 to sites
11 and 12, both of which have been shown to be capable of a role in
initiating replication in vitro (Sanders and Stenlund, 2000).
The herpesvirus protein Epstein Barr Nuclear Antigen 1 (EBNA-1)
has been compared to papillomavirus E2. Both are multifunctional
with roles in replication, transcription and viral genomemaintenance.
The DNA binding and dimerization domain of EBNA-1 folds in a beta-
barrel structure similar to E2 and binds to the cellular protein Brd4
during mitosis (Lin et al., 2008; Lindner and Sugden, 2007). The
genome of EBV is more than 20 times the size of the BPV-1 genome
and in contrast to the PV genome which may replicate several times
per S phase, replicates only once per cell cycle, being subject to the
restrictions of DNA licensing factors (Lindner and Sugden, 2007). ChIP
assays have placed a number of replication proteins at the EBV origin
(Chaudhuri et al., 2001). Our lab is currently using this protocol to
compare replicons and determine the cellular factors present during
PV replication. The use of ChIP combined with the restriction enzyme
digest (RED-ChIP) is a useful tool for ﬁner mapping of origins and
promoters in regions of the genome where these proposed sites can
be separated by a restriction enzyme. Utilizing this technique it
should be possible to analyze the occupancy of E2 binding sites
throughout the viral replicative program.
Materials and methods
Cell culture
The C127 A3 cells were a generous gift from M. Botchan. All cells
were cultured at 37 °C in Dulbecco's Modiﬁed Eagle Medium (Gibco)
with 10% fetal bovine serum, penicillin/streptomycin (100 U/ml) in
5% CO2. 1.4×106 cells were seeded in a 10 cm dish and 24 h later were
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100 ng/ml nocodazole for 12 h (M).
Chromatin immunoprecipitation (ChIP)
ChIP was performed using a protocol from Upstate Cell Signaling.
For restriction enzyme digestion coupled ChIP (RED-ChIP), cells were
treated with 0.33% formaldehyde and ChIP was performed according
to the manufacturer's instructions. Following immunoprecipitation
and washing, samples were resuspended in 100 μl of the appropriate
restriction enzyme digest buffer, 1% bovine serum albumin (BSA) and
either 30 U of BanII (New England Biolabs), 70 U high concentrate BglI
(Promega), 70 U of BglI and 8 U PﬂM1 (New England Biolabs), or no
enzyme. Following overnight digestion, samples were washed twice
with TE buffer and processed using the standard ChIP protocol.
PCR primersPrimer Sequence NucleotidesOrigin Primer set A Forward
Reversetcaaaatgcagcattatattttaagct
tggaacaccttgccaaagtcttc7867–297Upstream E2 Binding
region Primer set BForward
Reverseacacccggtacacatcctgt
ctgtctgtagtttaaggcg7205–7685BPV-1 LCR Primer
set CForward
Reverseaaagtttccattgcgtctgg
gctttttctagttagctggctatttt7522–67BS 16 and 17 Forward
Reverseggtggtagaggtggagtttgatg
agtagtagagcccagttccgtcag2953–3085L1 Forward
Reverseatctccctccaacccctgtaag
gcctgtttgtttcctgtcatctg5638–6039FACS
Brieﬂy, thymidine blocked A3 cells were washed with PBS then
trypsinized and washed once in DMEM with FBS, twice in PBS, then
centrifuged at 1000 rpm. The cell pellet was resuspended in 200 μl ice
cold PBS and gently agitated while 800 μl ice cold 100% ethanol was
added drop-wise and left at 4 °C overnight. Following ﬁxation, cells
were centrifuged at 1500 rpm for 5 min and ﬁxation buffer removed.
Samples were resuspended in 1 ml of propidium iodide (PI) staining
solution (glucose 1 g/L, RNase A 100 U/ml, propidium iodide
0.05 mg/ml in PBS buffer). Prior to FACS analysis (Becton Dickinson),
samples were incubated in the dark at room temperature for 30 min
and ﬁltered through gauze. Data were analyzed using FlowJo.
Antibodies
Rabbit anti-BPV-1 E1 antibodies INA, 1C1, 502-2 (Santucci et al.,
1990), rabbit anti-BPV-1 E2 antibody II-1 (Androphy et al., 1987),
monoclonal antibodies to E2 (B201 and B202) and anti-Brd4 rabbit
antibody AP8051a (Abgent) were used for ChIP experiments.
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